Congressional Digest

Healthcare Costs & the Insurance Industry

The Issue

This week, House Republicans held a high-profile hearing featuring CEOs from major health insurance companies, including UnitedHealthcare, CVS Health, Cigna, and Elevance Health. The hearing focused on rising healthcare costs, insurance industry practices, and the role of massive healthcare conglomerates in driving up prices for American families. Members of both parties questioned insurance executives about vertical integration, prior authorization abuses, pharmacy benefit managers (PBMs), and the overall affordability crisis facing patients and providers alike.

The hearing comes as Republicans and Democrats clash over healthcare funding and policy, with the appropriations process revealing deep divides over how to address costs while maintaining access to care. Several members highlighted constituent stories of denied care, skyrocketing premiums, and the struggle to navigate an increasingly complex and expensive healthcare system.

Verifiable Claims:

• "Republicans in Congress made huge cuts to Medicare and Medicaid and then falsely claimed it was about 'fighting fraud'" - stated by Rep. Mike Levin (D-CA)

• "When 15 million Americans lose their healthcare because of irresponsible Republican cuts to Medicaid in the Big Ugly Law, healthcare insurance companies CEOs will raise their premiums to cover the costs of uncompensated" care - stated by Rep. Raul Ruiz (D-CA)

• "This week, Ways and Means hosted a hearing with health insurance CEOs, to hold insurers accountable, because Texas families deserve answers, not excuses" - stated by Rep. Beth Van Duyne (R-TX)

• "Prices for the top 25 non-negotiated Medicare drugs have increased by an average of 67%" - stated by Sen. Kirsten Gillibrand (D-NY)

• "A new House Judiciary Committee report confirms what independent pharmacists have long warned us about. @CVSHealth used its power to stifle innovation, squeeze small pharmacies, and keep prices high" - stated by Rep. Troy Carter (D-LA)

Opinions & Characterizations:

• "While Billion-dollar insurance companies have stifled competition & hid prices, healthcare costs have skyrocketed. Newsflash: If you have to hide your prices, it's probably because you're screwing patients" - Rep. John James (R-MI)

• "What @Jim_Jordan, Chairman of House Judiciary Committee, has uncovered is extremely concerning and further demonstrates that vertical integration by massive insurance companies is driving up costs and harming patients" - Rep. John Joyce (R-PA)

• "When one corporation controls coverage, pricing, dispensing, and referrals, that's not competition — that's control. It's not just participating in the healthcare market. It's writing the rules of the market, and patients are the ones who pay the price" - Rep. Diana Harshbarger (R-TN)

• "Health insurance companies like UnitedHealth are skyrocketing costs, delaying critical services, and harming patients through their abuse of the prior authorization process" - Rep. Kim Schrier (D-WA)

• "This is the human side of health care policy. Real people sharing real experiences in a system that too often makes survival harder than it needs to be" - Rep. Steven Horsford (D-NV)

• "Companies must be held accountable when they do not uphold their role in protecting the health and safety of our communities" - Rep. Emilia Sykes (D-OH)

TL;DR - The Partisan Split:

Republicans focused their criticism on insurance company consolidation, vertical integration, and lack of price transparency, arguing that massive healthcare conglomerates are harming patients and independent providers. Democrats emphasized Republican cuts to Medicare and Medicaid, arguing these cuts will force insurance companies to raise premiums and ultimately harm working families who will lose coverage or face higher costs.

The Full Story:

The House Ways and Means Committee hearing this week put America's largest health insurance CEOs in the hot seat, forcing executives from UnitedHealthcare, CVS Health, Cigna, and Elevance Health to answer questions about skyrocketing healthcare costs and industry practices that critics say prioritize profits over patients. The hearing revealed a rare area of bipartisan concern—though Republicans and Democrats arrived at very different conclusions about the causes and solutions.

Republican members, led by Chairman Jason Smith and Judiciary Chairman Jim Jordan, focused intensely on the issue of vertical integration in the healthcare industry. The concern centers on massive corporations that own insurance companies, pharmacy benefit managers (PBMs), pharmacies, and even medical practices all under one roof. Rep. John Joyce asked pointedly why a health insurance company needs to own a bank, highlighting the sprawling financial empires these healthcare giants have built. Rep. John James summarized the Republican critique bluntly: "If you have to hide your prices, it's probably because you're screwing patients."

A House Judiciary Committee report released alongside the hearing detailed how CVS Health allegedly used its market power to suppress competition, squeeze independent pharmacies, and maintain high drug prices. Rep. Diana Harshbarger argued that when a single corporation controls every aspect of healthcare delivery—from insurance coverage to prescription fulfillment to provider networks—it's not participating in a market, it's controlling one, with patients bearing the costs. Rep. Beth Van Duyne emphasized that Texas families deserve answers from these insurance giants, not excuses.

Democrats approached the hearing from a different angle, focusing on recent Republican cuts to Medicare and Medicaid contained in what they call the "Big Ugly Law." Rep. Raul Ruiz, a physician, warned that when 15 million Americans lose healthcare coverage due to Medicaid cuts, insurance companies will simply raise premiums on everyone else to cover the costs of uncompensated care. Rep. Mike Levin accused Republicans of making massive cuts while falsely claiming they were simply fighting fraud. Sen. Kirsten Gillibrand pointed to data showing that prices for the top 25 non-negotiated Medicare drugs have increased by an average of 67%, arguing that Senate Democrats' drug price negotiation provisions need to be expanded, not rolled back.

Rep. Kim Schrier, also a physician, highlighted how insurance companies' abuse of the prior authorization process delays critical care and drives up costs. She called on UnitedHealth to fundamentally change its business model, which she said puts profits over patients' health. Rep. Steven Horsford shared testimony from a constituent describing the daily struggle to navigate a healthcare system that makes survival harder than necessary, emphasizing that real policy change requires understanding these human stories.

The hearing also touched on pharmacy benefit managers, the middlemen who negotiate drug prices between insurers, pharmacies, and drug manufacturers. Multiple members from both parties expressed concern that PBMs use offshore shell companies and complex financial arrangements to avoid passing rebates and savings on to employers and patients. Rep. Erin Houchin highlighted Kentucky pharmacists' concerns that insurance giants use these arrangements to maintain high costs without transparency.

While the hearing produced significant fireworks and rare bipartisan criticism of the insurance industry, the path forward remains deeply partisan. Republicans are pushing for increased transparency, limits on vertical integration, and reforms to PBM practices. Democrats argue these measures, while helpful, don't address the core problem: that millions of Americans are losing coverage due to Republican cuts, and that the solution requires expanding—not cutting—government programs that make healthcare affordable and accessible. Rep. Gwen Moore noted that Republicans repeatedly try to undermine the Affordable Care Act, which allows thousands of small businesses to insure their employees, even as they parade insurance CEOs to Washington for political theater.

The divide was perhaps best illustrated by competing visions for solving the cost crisis. Republicans emphasized market-based reforms, transparency requirements, and breaking up consolidated healthcare empires. Democrats pointed to the need for expanded Medicare drug price negotiations, restoration of ACA tax credits that Republicans allowed to expire, and rejection of cuts to Medicaid and Medicare. With both sides claiming to champion patients against powerful insurance companies, but proposing fundamentally different solutions, meaningful healthcare reform remains elusive despite the shared recognition that the current system is failing American families.